Streetbeat News

Analyst Ratings

SQM

Sociedad Quimica Y Minera (NYSE:SQM) was analyzed by 7 analysts, showing a mix of sentiments with 5 somewhat bullish, 1 indifferent, and 1 somewhat bearish. The average 12-month price target is now $70.21, down from $80.00, with a high estimate of $84.00 and a low of $54.50. Analysts from firms including Scotiabank, Goldman Sachs, JP Morgan, BMO Capital, and B of A Securities have adjusted their ratings and price targets. SQM's financial performance shows a -37.79% decline in revenue growth, a high net margin of 26.05%, an ROE of 9.44%, an ROA of 4.45%, and a debt-to-equity ratio of 0.7.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 7:00 pm

WFC

In the past three months, 7 analysts have published diverse ratings on Wells Fargo (NYSE:WFC), with recent updates showing a more bullish outlook. The average 12-month price target is now $54.58, up from $50.00. Analysts from firms like Barclays and Morgan Stanley have raised their price targets, reflecting positive sentiment. Wells Fargo's financial performance shows strong net margin and ROE, with a revenue growth of 6.6% as of September 30, 2023, but trails behind the Financials sector average growth rate.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 7:00 pm

LBPH

UCBJF

UCBJY

Longboard Pharmaceuticals Inc (NASDAQ:LBPH) released positive topline data from the PACIFIC Phase 1b/2a study for its anti-seizure candidate bexicaserin, showing a median 53% reduction in seizures. Cantor Fitzgerald raised LBPH's price target from $35 to $55 and maintained an overweight rating, citing the drug's potential to achieve over $1 billion in peak sales. LBPH shares surged 222.60% to $19.45 following the news.

Portfolio Pulse from Vandana Singh

January 02, 2024 | 6:55 pm

AMZN

BBY

KSS

LEVI

LULU

LVMHF

NKE

ULTA

WMT

WSM

Telsey Advisory Group analyst Dana Telsey's study based on Google Trends insights revealed that Black Friday attracted more consumer interest for most brands compared to Christmas. Larger and more established brands like Amazon, Walmart, Nike, UGG, and Kohl's were the winners. Lululemon stood out in specialty apparel, while Ulta Beauty and Sephora saw increased interest in the beauty segment. Coach was preferred over Michael Kors and Kate Spade in luxury, and LVMH excelled among premium European luxury brands. Kohl's led department stores and off-price retailers, with The North Face, Ralph Lauren, and Levi Strauss being popular in apparel. Amazon and Best Buy were top in their segments, and Williams-Sonoma in furniture. Interest in off-price and athletic brands increased around Christmas.

Portfolio Pulse from Lekha Gupta

January 02, 2024 | 6:54 pm

BBWI

Goldman Sachs analyst Kate McShane has reaffirmed a Buy rating on Bath & Body Works (NYSE:BBWI) and added the company to the Goldman Sachs Conviction List, indicating a strong confidence in the stock's potential performance.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 6:52 pm

GDRX

LBPH

MRNA

MSTR

RIVN

VYGR

Longboard Pharmaceuticals, Inc. (LBPH) shares soared by approximately 200% after announcing positive topline data from their PACIFIC Phase 1b/2a study of bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs). Other stocks experienced significant movement in Tuesday's mid-day session, with various companies seeing substantial gains or losses.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 6:35 pm

VNRX

EF Hutton analyst Tim Moore has reiterated a Buy rating on VolitionRX (AMEX:VNRX) and maintained a price target of $4.5 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 6:34 pm

AAPL

DIA

IBB

MRNA

NVDA

QQQ

RIVN

SMH

SOXX

SPY

TSLA

XLK

XLV

Wall Street began 2024 with declines in major indices, particularly the S&P 500 and Nasdaq 100, dragged down by the tech sector. Tesla (TSLA) remained flat, while Apple (AAPL) and NVIDIA (NVDA), along with semiconductor ETFs like SOXX, saw significant drops. The decline in tech stocks was partly due to a White House request to limit chip exports to China. The dollar and Treasury yields surged, while commodities had a mixed day. Bitcoin (BTC) rose, anticipating a Bitcoin ETF approval. Sector ETFs like SPY, DIA, and QQQ moved in line with their respective indices, while XLV outperformed and XLK lagged. Biotech stocks and ETFs like IBB performed well, whereas semiconductor ETFs like SMH declined. Moderna (MRNA) surged after an Oppenheimer upgrade, while Rivian (RIVN) and cruise lines like NCLH and RCL saw stock price declines.

Portfolio Pulse from Piero Cingari

January 02, 2024 | 6:29 pm

VYGR

Wells Fargo analyst Yanan Zhu has upgraded Voyager Therapeutics (VYGR) from Equal-Weight to Overweight and increased the price target from $9 to $14.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 6:27 pm

CORT

HC Wainwright & Co. analyst Swayampakula Ramakanth has maintained a Buy rating on Corcept Therapeutics (NASDAQ:CORT) but has reduced the price target from $34 to $28.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 6:21 pm